EP0525499A1 — Amide derivatives of antibiotic A 40926
Assigned to Gruppo Lepetit SpA · Expires 1993-02-03 · 33y expired
What this patent protects
The present invention is directed to novel antibiotic A 40926 derivatives characterized by having a carboxy, (C 1 -C 4 )alkoxycarbonyl, aminocarbonyl, (Ci-C4)alkylaminocarbonyl, di(C 1 -C 4 )alkylaminocarbonyl or hydroxymethyl substituent on the N-acylaminoglucuronyl moiety and a…
USPTO Abstract
The present invention is directed to novel antibiotic A 40926 derivatives characterized by having a carboxy, (C 1 -C 4 )alkoxycarbonyl, aminocarbonyl, (Ci-C4)alkylaminocarbonyl, di(C 1 -C 4 )alkylaminocarbonyl or hydroxymethyl substituent on the N-acylaminoglucuronyl moiety and a hydroxy or a polyamine substituent in position 63 of the molecule. The compounds of the invention show high in vitro activity against glycopeptide resistant Enterococci and Staplylococci.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.